Disci/Viscum comp. cum Stanno Creme

Country: Switzerland

Language: German

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

disci intervertebrales bovis Gl (HAB) D3, equisetum arvense ex herba sicc. ferm 35b D1 (HAB 35b), formica rufa et formica polyctena ex animale toto Gl D3 (HAB 41c), phyllostachys viridiglaucescens e nodo rec. ferm 35c D1 (HAB 35c), stannum metallicum (HAB) D4, viscum album (mali) e planta tota recens ferm 34i D1 (HAB 34i)

Available from:

WALA Schweiz AG

INN (International Name):

disci intervertebrales bovis Gl (HAB) D3, equisetum arvense ex herba sicc. ferm 35b D1 (HAB 35b), formica rufa et formica polyctena ex animale toto Gl D3 (HAB 41c), phyllostachys viridiglaucescens e nodo rec. ferm 35c D1 (HAB 35c), stannum metallicum (HAB) D4, viscum album (mali) e planta tota recens ferm 34i D1 (HAB 34i)

Pharmaceutical form:

Creme

Composition:

disci intervertebrales bovis Gl (HAB) D3 10 mg, equisetum arvense ex herba sicc. ferm 35b D1 (HAB 35b) 10 mg, formica rufa et formica polyctena ex animale toto Gl D3 (HAB 41c) 10 mg, phyllostachys viridiglaucescens e nodo rec. ferm 35c D1 (HAB 35c) 10 mg, stannum metallicum (HAB) D4 10 mg, viscum album (mali) e planta tota recens ferm 34i D1 (HAB 34i) 10 mg, adeps lanae 270 mg, vaselinum album, arachidis oleum 405 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, ad unguentum pro 1 g.

Class:

D

Therapeutic group:

Anthroposophische Arzneimittel

Therapeutic area:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

Authorization status:

zugelassen

Authorization date:

2013-06-21